Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-01-02
2007-01-02
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S045000, C536S027100, C536S027130, C536S027200, C536S027210, C536S027300, C536S027620
Reexamination Certificate
active
10855471
ABSTRACT:
Disclosed are novel compounds that are partial and full A1adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.
REFERENCES:
patent: 6258793 (2001-07-01), Palle et al.
patent: 6946449 (2005-09-01), Elzein et al.
patent: 0181129 (1986-05-01), None
patent: WO 99/24449 (1999-05-01), None
patent: WO 99/24450 (1999-05-01), None
patent: WO 99/24451 (1999-05-01), None
patent: WO 99/67262 (1999-12-01), None
patent: WO 01/40243 (2001-06-01), None
Van Der Wenden, E. et al: “5′-Substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor” J. Med Chem 1998, 41, pp. 102-108.
Tilburg, E. et al: “N6.5′-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor”, J. Med Chem, 1999, 42, pp. 1393-1400.
Smejkal, R.M. et al: “Muscarinic receptor subtype specificity of 5′(isobutylthio)-adenosine (SIBA) and its analogues”, Gen Pharmac., 20(3) pp. 385-392, 1989.
Elzein Elfatih
Ibrahim Prabha
Palle Venkata
Varkhedkar Vaibhav
Zablocki Jeff
CV Therapeutics Inc.
CV Therapeutics, Inc.
Hartrum J. Elin
Jiang Shaojia Anna
Lewis Brian
LandOfFree
Partial and full agonists of A1 adenosine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Partial and full agonists of A1 adenosine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Partial and full agonists of A1 adenosine receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3807378